Exciting News! Mind's Journey & Nervana Medical Are Coming Together to provide even more services
Ketamine therapy has garnered attention for its potential benefits to high-performing professionals, particularly in addressing mental health challenges such as stress, burnout and anxiety.
High performing professionals such as leadership teams and executives often face high-pressure environments, decision fatigue, and chronic stress, which can lead to mental exhaustion, depression, and reduced cognitive function. Ketamine therapy offers:
✅ Rapid relief from stress & depression – Works within hours to days, unlike traditional antidepressants.
✅ Enhanced cognitive flexibility – May improve problem-solving, creativity, and adaptability.
✅ Reduction in anxiety – Helps with decision-making under pressure.
✅ Improved emotional resilience – Supports better leadership and interpersonal dynamics.
✅ Better work-life balance – Can aid in managing burnout and emotional well-being.
Book your consultation now!
https://www.nervanamedical.com/
References
Ketamine has emerged as a promising treatment for individuals with treatment-resistant depression (TRD), offering rapid relief when traditional therapies fail. Recent research has shown that while a single ketamine infusion can provide short-term benefits, repeated and maintenance infusions are more effective at sustaining improvements in mood and preventing relapse. This study explores the impact of single, repeated, and long-term ketamine therapy in managing TRD, highlighting its potential as a life-changing treatment option. Read more on some of the driving factors that led our Ketamine team at Nervana Medical to believe that group treatments were necessary to provide a cheaper alternative to help people maintain their mental health at a more affordable rate.
The study Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial (Phillips et al., 2019) examined the effects of single, repeated, and maintenance ketamine infusions in patients with treatment-resistant depression (TRD). Here are the key findings:
Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial Jennifer L Phillips 1, Sandhaya Norris 1, Jeanne Talbot 1, Meagan Birmingham 1, Taylor Hatchard 1, Abigail Ortiz 1, Olabisi Owoeye 1, Lisa A Batten 1, Pierre Blier 1 PMID: 30922101 DOI: 10.1176/appi.ajp.2018.18070834